The Milken Institute Future of Health Summit – “Is AI Just What the Doctor-or Patient-Ordered?” Panel Discussion

The Milken Institute Future of Health Summit (FHS) convened the best minds in the world to confront the most significant health challenges by matching human, financial, and scientific resources with the most innovative, inclusive, and impactful ideas. Watch now the Future of Health Summit and the panel titled “Is AI Just What the Doctor-or Patient-Ordered?” […]

Intelligent Technology Brings Companies To A New Moment Of Truth

“Algorithms have long been used to uncover correlations but now they are closing in on more human-like abilities such as common sense and the understanding of causation.” Paul R. Daugherty and H. James Wilson, discuss in this article the future of AI and refer to it as A New Moment of Truth. GNS causal AI […]

GNS Healthcare Chosen to Present  Discovery of New Clinical Predictors of Overall Survival in Metastatic Colorectal Cancer at ESMO 2019 in Collaboration with the Alliance for Clinical Trials in Oncology

AI-driven in silico patients used to identify heterogeneous landscape of clinical predictors of overall survival in populations of patients with metastatic colorectal cancer. CAMBRIDGE, Mass.– [July 2, 2019] – GNS Healthcare (GNS), a leading precision medicine company, together with the Alliance for Clinical Trials in Oncology (Alliance), is presenting discoveries of  predictive biomarkers for metastatic colorectal cancer […]

GNS Healthcare Announces Collaboration to Power Cancer Drug Development with REFS™ Causal Machine Learning and Simulation AI Platform

CAMBRIDGE, Mass.– June 19, 2017 – GNS Healthcare (GNS), a leading precision medicine company, today announced a collaboration with Genentech, a member of the Roche Group to leverage GNS REFS™ (Reverse Engineering and Forward Simulation) causal machine learning and simulation platform to power the development of novel cancer therapies. The GNS technology turns large and diverse […]

Global Genomics Group (G3) and GNS Healthcare Report Preliminary Results of Largest-Ever Study Linking Biomarkers with Coronary Artery Disease

Study Applies GNS’s Causal Machine Learning to G3’s G3LOBAL DatabaseTM Study Demonstrates Proof of Concept of Approach with Identification of Known Coronary Disease-Associated Pathway ATLANTA, Ga. and CAMBRIDGE, Mass. – Jan. 8, 2016 – Global Genomics Group (G3), a life sciences company that leverages large-scale genomic and molecular disease profiles to develop life-changing diagnostics and therapeutics, […]

Alliance for Clinical Trials in Oncology and GNS Healthcare Launch Big Data Initiative to Transform Metastatic Colorectal Cancer Treatment

Partners to Apply Causal Machine Learning and Simulation to Combination Treatment Regimens to Discover Biomarkers of Clinical Response to Treatment CHICAGO, Ill. and CAMBRIDGE, Mass. – Dec. 15, 2015 – The Alliance for Clinical Trials in Oncology (the Alliance), one of the five cooperative research groups in the United States sponsored by the National Cancer […]